Syngene International Ltd

Syngene International Ltd has announced the resignation of Mr. Peter Bains from his positions as Managing Director & Chief Executive Officer (Key Managerial Personnel). His resignation is effective from the close of business hours on June 30, 2026. The company has submitted Mr. Bains' resignation letter as per SEBI Listing Regulations. Mr. Bains expressed his commitment to ensuring a smooth leadership transition and reflected on his tenure, expressing gratitude to the Board, colleagues, and stakeholders. The company will make this information available on its website.

Syngene International Ltd has announced its 33rd Annual General Meeting (AGM) will be held on Wednesday, July 29, 2026, at 3:30 pm IST via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also released its Annual Report for FY 2025-26. Shareholders registered with the company will receive the notice and report electronically. A cut-off date of Wednesday, July 22, 2026, has been set for determining eligibility for remote e-voting and voting at the AGM. Remote e-voting will be open from Friday, July 24, 2026, 09:00 hours IST to Tuesday, July 28, 2026, 17:00 hours IST. The final dividend record date is June 26, 2026, with payment within 30 days of shareholder approval.

Syngene International Ltd has announced its 33rd Annual General Meeting (AGM) will be held on Wednesday, July 29, 2026, at 3:30 PM IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, declaration of a final dividend of ₹1.25 per equity share, re-appointment of Professor Catherine Rosenberg as Director, and appointment of M/s S. R. Batliboi & Associates LLP as statutory auditors for a term of five years. The company will also seek approval for remuneration to directors in case of absence/inadequate profits.

Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer, effective July 1, 2026. Mittal succeeds Peter Bains and brings nearly three decades of business leadership experience. He joins Syngene from Biocon Limited, where he previously served as Managing Director and CEO, and before that, as Chief Financial Officer. During his tenure at Biocon, he played a key role in shaping strategic direction, strengthening commercial operations, expanding global presence, and securing regulatory approvals. Kiran Mazumdar-Shaw, Executive Chairperson of Syngene, expressed confidence in Mittal's ability to drive transformation and sustainable growth. Mittal stated his immediate priorities include sharpening commercial edge, strengthening delivery excellence, and enhancing execution focus to restore growth momentum.

Syngene International Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent insider trading during periods of sensitive financial information disclosure.

Syngene International Ltd has communicated to its shareholders regarding the Tax Deducted at Source (TDS) on the proposed final dividend for the Financial Year 2025-26. The Board recommended a final dividend of 12.50% (₹1.25 per equity share). This dividend is subject to shareholder approval at the AGM on July 29, 2026. The record date for determining eligible shareholders is June 26, 2026. The company will deduct TDS as per the Income-tax Act, 2025, with rates varying based on shareholder status and documentation. Shareholders are urged to update their PAN, address, and residential status with their depositories or the company's RTA, KFin Technologies Limited, to ensure correct TDS application.

Syngene International Ltd has issued a reminder to shareholders to claim unclaimed dividends for FY 2018-19 onwards and update their KYC information, as per Regulation 30 of SEBI Listing Obligations. Shareholders are requested to claim dividends by August 21, 2026, to avoid transfer to the Investor Education and Protection Fund (IEPF). The company has also requested shareholders to update their KYC information.

Syngene International Ltd's board approved the voluntary liquidation of its wholly-owned subsidiary, Syngene Manufacturing Solutions Limited (SMSL), as per the Insolvency and Bankruptcy Code, 2016. SMSL, a non-material subsidiary with no business operations, will be liquidated as a solvent company, pending necessary approvals. The liquidation is not expected to affect Syngene's consolidated financials. SMSL's turnover was Nil, and its net worth was ₹93.97 Lakh as of March 31, 2026.

Syngene International Ltd's Board of Directors, at its meeting on April 29, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board recommended a final dividend of Re.1.25 per Equity Share of Rs. 10/- for FY2025-26, with the record date set as June 26, 2026. The dividend will be paid within 30 days of shareholder approval. Additionally, M/s S. R. Batliboi & Associates LLP were approved as statutory auditors for a five-year term, subject to shareholder approval. The 33rd Annual General Meeting is scheduled for July 29, 2026.

Syngene International Ltd.'s Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹1.25 per equity share (face value ₹10) for FY26, with June 26, 2026, as the record date. Subject to shareholder approval, M/s S. R. Batliboi & Associates LLP were appointed as statutory auditors for a five-year term, commencing from the 33rd Annual General Meeting (AGM) until the 2031 AGM. The 33rd AGM is scheduled for July 29, 2026. The board also approved managerial remuneration for Ms. Kiran Mazumdar-Shaw.